Himadri Speciality Chemical Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Himadri Speciality Chemical Ltd is ₹ 452.25 as of 20 Mar 15:30 . The P/E Ratio of Himadri Speciality Chemical Ltd changed from 36.9 on March 2021 to 37.7 on March 2025 . This represents a CAGR of 0.43% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of Himadri Speciality Chemical Ltd changed from ₹ 1747 crore on March 2021 to ₹ 20929 crore on March 2025 . This represents a CAGR of 64.32% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of Himadri Speciality Chemical Ltd for the Dec '25 is ₹ 1230 crore as compare to the Sep '25 revenue of ₹ 1106 crore. This represent the growth of 11.13% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Himadri Speciality Chemical Ltd for the Dec '25 is ₹ 289.2 crore as compare to the Sep '25 ebitda of ₹ 268.71 crore. This represent the growth of 7.63% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Himadri Speciality Chemical Ltd changed from ₹ 122.78 crore to ₹ 192.04 crore over 7 quarters. This represents a CAGR of 29.12% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of Himadri Speciality Chemical Ltd changed from 13.47 % on March 2021 to 5.31 % on March 2025 . This represents a CAGR of -16.99% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About Himadri Speciality Chemical Ltd

Himadri Speciality Chemical Limited, formerly known as Himadri Chemicals & Industries Limited, is the flagship of Himadri Group.
The Company was incorporated on July 28, 1987, which changed to Himadri Speciality Chemical Limited in June, 2016.
The Company is primarily engaged in manufacturing of carbon materials and chemicals.
It has operations in India and caters to domestic and international markets.
It has a wholly-owned subsidiary in India in the name of AAT Global Limited, incorporated in Hong Kong and a step down subsidiary with 94% shareholding in the name of Shandong Dawn Himadri Chemical Industry Ltd, incorporated in China. The Company was founded to develop, manufacture and market chemical products with a special emphasis on coal tar and its derivatives.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of Himadri Speciality Chemical Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, Himadri Speciality Chemical Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of Himadri Speciality Chemical Ltd is 22,817 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,637 Cr

What are the key factors driving the stock performance of Himadri Speciality Chemical Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of Himadri Speciality Chemical Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Himadri Speciality Chemical Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 22, 2026, the Himadri Speciality Chemical Ltd stock price is INR ₹452.25. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1127.45.

How do dividend payouts of Himadri Speciality Chemical Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of Himadri Speciality Chemical Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.